Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reflect strong engagement with the article, with users referencing specific statistics such as the reported 4.5% incidence of ME/CFS in COVID-19 survivors compared to 0.6% in uninfected individuals. Several users express urgency, describing the findings as 'alarming' and emphasize the need for greater awareness and funding to support those affected, using phrases like 'urgent need' and 'transformative potential'. This choice of language creates a tone of urgency and seriousness, highlighting the perceived significance of the research findings.
Many discussions express support for the findings, indicating a moderate level of agreement with the conclusions of the study regarding the incidence of ME/CFS post-COVID-19.
The posts show a strong interest in the implications of the research, especially given the rising number of discussed cases.
While there are some dismissive responses, a majority of the discussions demonstrate engagement, particularly when discussing the methodologies and data interpretations.
Users perceive the article as having significant implications for future healthcare understanding, suggesting it could change how post-COVID conditions are addressed.
I may be famous for my lack of rigor and credibility in insisting that post COVID ME exists on the basis of the physiological data, but don’t take my word for it. Behold! Epidemiology. ☺️ https://t.co/V640ZKLcvq
According to a new longitudinal study from the NIH RECOVER initiative, a SARS-CoV-2 infection increases your risk of developing ME/CFS by 393%. Here are the study cliff notes... Full study: https://t.co/SWxkaEL8Rf
1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study' 'RECOVER provides an unprecedented opportunity to study post-COVID-19 ME/CFS.' https://t.co/BMYxhJaiEI
新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
Long COVID経験率(有病ではない)は軽症/無症状で10%、中等症で28%、再感染では1.4倍という報告。再感染は初感染の半分程の発生率か。 https://t.co/sQ3z9ytawS コロナ後の慢性疲労症候群発症が100人年あたり2.7という報告も(この調査では非感染でも0.9と高く、過大評価かと)。 https://t.co/ALuYByLE38 https://t.co/GbPoDGmXFw
アメリカの研究で、コロナ感染後のME/CFSの発症率はパンデミック前の約15倍であったと。一昨日出たばかりの新しい論文ですね
Join Edward Pratt of Edward Pratt Martial Arts Concepts as he leads a mindfulness experience focused on Tai Chi Chuan. This practice promotes health and wellness by enhancing leg strength and improving balance, aiding…
In her latest paper, Suzanne Vernon PhD discusses the alarming rise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MECFS) prevalence, which is now 15 times higher than pre-pandemic estimates. The study, part of…
@RorPreston Dunno if you're aware of this one
RT @sunsopeningband: I may be famous for my lack of rigor and credibility in insisting that post COVID ME exists on the basis of the physio…
RT @sunsopeningband: I may be famous for my lack of rigor and credibility in insisting that post COVID ME exists on the basis of the physio…
RT @sunsopeningband: I may be famous for my lack of rigor and credibility in insisting that post COVID ME exists on the basis of the physio…
Incidence, Prevalence of Post-COVID19 Myalgic Encephalomyelitis:incidence rate of ME/CFS followed from time of SARSCoV2 was 2.66/100 person-years;rate in matched uninfected was 0.93/100 person-years:HR of 4.93. https://t.co/19cuuyQJBf
RT @sunsopeningband: I may be famous for my lack of rigor and credibility in insisting that post COVID ME exists on the basis of the physio…
RT @sunsopeningband: I may be famous for my lack of rigor and credibility in insisting that post COVID ME exists on the basis of the physio…
RT @sunsopeningband: I may be famous for my lack of rigor and credibility in insisting that post COVID ME exists on the basis of the physio…
RT @sunsopeningband: I may be famous for my lack of rigor and credibility in insisting that post COVID ME exists on the basis of the physio…
RT @sunsopeningband: I may be famous for my lack of rigor and credibility in insisting that post COVID ME exists on the basis of the physio…
I may be famous for my lack of rigor and credibility in insisting that post COVID ME exists on the basis of the physiological data, but don’t take my word for it. Behold! Epidemiology. ☺️ https://t.co/V640ZKLcvq
@coffndrop Yes it looks like Sars-Cov-2 increases ME/CFS incidence, similar to other viral illnesses: https://t.co/T8RXmyXybv
RT @sunsopeningband: @FionaPWME @MECFSNanoneedle The best constructed study to date is the one by Vernon. It says 4.5% of all cases (infect…
RT @sunsopeningband: @FionaPWME @MECFSNanoneedle The best constructed study to date is the one by Vernon. It says 4.5% of all cases (infect…
@FionaPWME @MECFSNanoneedle The best constructed study to date is the one by Vernon. It says 4.5% of all cases (infections) go on to meet ME/CFS criteria. A massive number. Large frequency of diagnostic overlap meeting both ME and Long Covid criteria in this cohort. https://t.co/0NWNNxG3sk
@martinruecker @dg_mecfs PEM hat eine sehr hohe Spezifität & wird abhängig von der Dauer auch als pathognomisch für ME angesehen. Ist also differentialdiagnostisch richtungsweisend. Die DGN bildet ein Forschungsstand ab, wo Fukuda noch gängig war. LC PEM & ME Vernon et al 2025: https://t.co/nkTEzlU1Rj
8/8 source SD Vernon et al., Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study, Journal of General Internal Medicine, 2025.
Research reveals a 15x increase in chronic condition after COVID-19. Here’s what scientists are uncovering about Long COVID’s lasting effects. 1/8
According to these study summaries, the ME/CFS risk ratio appears to be well below 15x. How was 15x risk calculated? * link.springer.com/article/10.1... * www.nih.gov/news-events/... * pubmed.ncbi.nlm.nih.gov/39804551/ * ..
A recent study estimated 1 in 22 Covid infections result in #MECFS https://t.co/kzbcofuKxu
RT @LauraCayuela7: 27. Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult S…
RT @LauraCayuela7: 27. Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult S…
RT @LauraCayuela7: 27. Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult S…
27. Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study (2025). El 4,5% (1 de cada 22) de infectados con Sars-Cov-2 desarrolla encefalomielitis miálgica vs el 0,6% de no infectados. https://t.co/RdYbzE5k7X
RT @useless_priest: @FraserNelson 1 in 22 (4.5%) of COVID infections have led to ME/CFS (NIH) https://t.co/qedlEpTz1b).
RT @useless_priest: @FraserNelson 1 in 22 (4.5%) of COVID infections have led to ME/CFS (NIH) https://t.co/qedlEpTz1b).
RT @useless_priest: @FraserNelson 1 in 22 (4.5%) of COVID infections have led to ME/CFS (NIH) https://t.co/qedlEpTz1b).
@FraserNelson 1 in 22 (4.5%) of COVID infections have led to ME/CFS (NIH) https://t.co/qedlEpTz1b).
A recent NIH study shows 4.5% of adults post-COVID now meet criteria for ME/CFS. That’s nearly 1 in 22 Americans. Our guide helps providers recognize it. Your $5 makes that happen.
Incidence and prevalence of post-COVID-19 myalgic encephalomyelitis: A report from the observational RECOVER-Adult study | RECOVER COVID Initiative #MECFS #PCME #PostCOVIDME https://t.co/NDTuqzlqSE
Incidence and prevalence of post-COVID-19 myalgic encephalomyelitis: A report from the observational RECOVER-Adult study Vernon, SD; Zheng, T; Do, H; et al., Journal of General Internal Medicine #ME/CFS #PCME #PostCOVIDME recovercovid.org/publications...
RT @sunsopeningband: @PeteUK7 Maybe seeing crossover in a study would be more convincing. https://t.co/kxIuhSNnu9
@PeteUK7 Maybe seeing crossover in a study would be more convincing. https://t.co/kxIuhSNnu9
For Epstein Barr Virus, Ross River Virus, and Q fever, about 10% of adults get #MECFS. The figure for the ordinary flu appears to be unknown, but if I had to guess it's probably around 2%. link to the COVID study : https://t.co/j7WMFlbVKC
RT @pzneedsrest: https://t.co/kzbcofuKxu
https://t.co/kzbcofuKxu
https://t.co/HT2wqu6HD7
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study | Journal of General Internal Medicine https://t.co/gAvKCXXjzH
Reference: https://t.co/HT2wqu6HD7
RT @verenabee: https://t.co/ngcly4lu4U @FFHambu: Kannst Du die Zahlen von "Results" erklären, den Unterschied zw. 2,66% per 100 person yea…
https://t.co/ngcly4lu4U @FFHambu: Kannst Du die Zahlen von "Results" erklären, den Unterschied zw. 2,66% per 100 person years und 4,5% der Teilnehmer haben ME/CFS? Was bedeutet der erste Wert und woher der Unterschied?
RT @pzneedsrest: @TheWHN Hey @TheWHN Strange you've omitted that Covid can result in #MECFS... The "mitochondrial dysfunction" you mention…
@TheWHN Hey @TheWHN Strange you've omitted that Covid can result in #MECFS... The "mitochondrial dysfunction" you mention is a factor in ME/CFS - of which 1 in 22 Covid infections result in. A historically neglected illness which you seem to be... neglecting. https://t.co/HT2wqu6HD7
@FFHambu https://t.co/A2zo2at7OX Ganz interessanter Artikel über das relative Risiko MECFS nach COVID-19 zu entwickeln.
https://t.co/A2zo2aszZp
RT @maki_cfs: COVID-19後の筋痛性脳脊髄炎の発生率と有病率：RECOVER-Adult観察研究からの報告 米国全土で実施された縦断的観察コホート研究。 https://t.co/qIc0BmkCZw
COVID-19後の筋痛性脳脊髄炎の発生率と有病率：RECOVER-Adult観察研究からの報告 米国全土で実施された縦断的観察コホート研究。 https://t.co/qIc0BmkCZw
RT @uCqGB3EYcs4353: Long COVID経験率(有病ではない)は軽症/無症状で10%、中等症で28%、再感染では1.4倍という報告。再感染は初感染の半分程の発生率か。 https://t.co/sQ3z9ytawS コロナ後の慢性疲労症候群発症が100人年あ…
RT @dbdugger: @chantz_y @washingtonpost Unfortunately, you believed them deserving of forty years of evidenced based medicine, drawing para…
@chantz_y @washingtonpost Unfortunately, you believed them deserving of forty years of evidenced based medicine, drawing parallels to ME/CFS. Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study https://t.co/m6Wfg6Kelv
@mecfsskeptic Yes, there is no high quality data. But I don't think we should ignore for example this one https://t.co/vfI6kg5MPY and pretend that we know nothing or prevalence hasn't changed since 2020.
@lazerwalker @robinsoped101 @SalvMattera And here's a recent study on prevalence of ME/CFS following C19 infection https://t.co/kzbcofuKxu
@1goodtern Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study https://t.co/m6Wfg6KMb3
#MillionsMissing #MillionsMoreMissing #MyalgicE #ChronicIllness #IACC #PIDS #CovidRoulette #CovidDamages #EBV #LymeDisease pubmed.ncbi.nlm.nih.gov/39804551/
@Opinions_Survey @elle_carnitine @x3r0gx4 I think Elle is referring to this study, but the figure is 1 in 20 developed full blown ME - here they followed 11,785 infected people. But if it's another one I'd be happy to see it too. https://t.co/Sh5Cg3RTbQ
@FFHambu https://t.co/1uL1ToDc3R
RT @BatemanHorne: @OpenMedF Source: https://t.co/gsRUt1nuLB
@OpenMedF Source: https://t.co/gsRUt1nuLB
RT @pzneedsrest: https://t.co/HT2wqu6HD7
RT @pzneedsrest: https://t.co/HT2wqu6HD7
RT @pzneedsrest: https://t.co/HT2wqu6HD7
2. Vernon, SD., Zheng, T., Do, H. et al. Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study. J Gen Intern Med. (2025) doi.org/10.1007/s116...
@sam164__ On the other end of the spectrum, a study which recruited patients at acute infection found that 1 in 60 developed ME severe enough that they had moderate, severe, or complete difficulty in walking, climbing stairs, or moving a chair https://t.co/uoDJuw2kdx
https://t.co/HT2wqu6HD7
https://t.co/JUAJwqBATd
RT @uCqGB3EYcs4353: Long COVID経験率(有病ではない)は軽症/無症状で10%、中等症で28%、再感染では1.4倍という報告。再感染は初感染の半分程の発生率か。 https://t.co/sQ3z9ytawS コロナ後の慢性疲労症候群発症が100人年あ…
RT @uCqGB3EYcs4353: Long COVID経験率(有病ではない)は軽症/無症状で10%、中等症で28%、再感染では1.4倍という報告。再感染は初感染の半分程の発生率か。 https://t.co/sQ3z9ytawS コロナ後の慢性疲労症候群発症が100人年あ…
RT @uCqGB3EYcs4353: Long COVID経験率(有病ではない)は軽症/無症状で10%、中等症で28%、再感染では1.4倍という報告。再感染は初感染の半分程の発生率か。 https://t.co/sQ3z9ytawS コロナ後の慢性疲労症候群発症が100人年あ…
RT @uCqGB3EYcs4353: Long COVID経験率(有病ではない)は軽症/無症状で10%、中等症で28%、再感染では1.4倍という報告。再感染は初感染の半分程の発生率か。 https://t.co/sQ3z9ytawS コロナ後の慢性疲労症候群発症が100人年あ…
RT @uCqGB3EYcs4353: Long COVID経験率(有病ではない)は軽症/無症状で10%、中等症で28%、再感染では1.4倍という報告。再感染は初感染の半分程の発生率か。 https://t.co/sQ3z9ytawS コロナ後の慢性疲労症候群発症が100人年あ…
RT @uCqGB3EYcs4353: Long COVID経験率(有病ではない)は軽症/無症状で10%、中等症で28%、再感染では1.4倍という報告。再感染は初感染の半分程の発生率か。 https://t.co/sQ3z9ytawS コロナ後の慢性疲労症候群発症が100人年あ…
Long COVID経験率(有病ではない)は軽症/無症状で10%、中等症で28%、再感染では1.4倍という報告。再感染は初感染の半分程の発生率か。 https://t.co/sQ3z9ytawS コロナ後の慢性疲労症候群発症が100人年あたり2.7という報告も(この調査では非感染でも0.9と高く、過大評価かと)。 https://t.co/ALuYByLE38 https://t.co/GbPoDGmXFw
RT @nbykudn_udon: アメリカの研究で、コロナ感染後のME/CFSの発症率はパンデミック前の約15倍であったと。一昨日出たばかりの新しい論文ですね
RT @TomKindlon: New US research Incidence & Prevalence of Post‑COVID‑19 Myalgic Encephalomyelitis:A Report from the Observational RECOVER‑…
“Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study.” Publié en janvier dans J Gen Intern Med. #Medsky #IDSky #COVID rdcu.be/d8DQ0
RT @carpe_diem0820: Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Stud…
RT @carpe_diem0820: Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Stud…
RT @carpe_diem0820: Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Stud…
RT @carpe_diem0820: Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Stud…
RT @carpe_diem0820: Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Stud…
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study 米国の大規模研究（RECOVER-Adult）は、新型コロナウイルス感染後の筋痛性脳脊髄炎/慢性疲労症候群（ME/CFS）の発症率と有病率を調査した。 https://t.co/21GXSr7TzB
RT @Angama_Market: COVID-19後の成人でME/CFS（筋痛性脳脊髄炎/慢性疲労症候群）発症率が約5倍に増加。感染から6か月以上後の追跡調査で、11,785人中4.5%がME/CFS診断基準を満たす一方、非感染者では0.6%。疲労や倦怠感の症状が日常生活に…
RT @NydtyV3ODjb3cEB: 新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
RT @EARL_med_tw: J Gen Intern Med 2025 Jan.13
「SARS-CoV-2感染後にME/CFSの基準を満たしたRECOVER-Adult参加者の割合は4.5％（11,785人中531人）であったのに対し、非感染者では0.6％（1439人中9人）であった」(Result) https://t.co/viY7EGVaUd
Quand au risque de ME/CFS, maladie chroniqe invalidante et incurable, il est de 4.5 % https://t.co/zvFJODgkto
RT @EARL_med_tw: J Gen Intern Med 2025 Jan.13
J Gen Intern Med 2025 Jan.13
RT @NydtyV3ODjb3cEB: 新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
RT @jorgenponder: Enligt denna studie i USA femdubblar Covid risken för ME/CFS. Självrapporterade symtom vid besök och med en osmittad jämf…
https://t.co/veoQ01ZjPL
RT @NydtyV3ODjb3cEB: 新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
RT @NydtyV3ODjb3cEB: 新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
RT @NydtyV3ODjb3cEB: 新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
RT @NydtyV3ODjb3cEB: 新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
RT @NydtyV3ODjb3cEB: 新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
RT @NydtyV3ODjb3cEB: 新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
RT @NydtyV3ODjb3cEB: 新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
RT @NydtyV3ODjb3cEB: 新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
RT @NydtyV3ODjb3cEB: 新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
RT @NydtyV3ODjb3cEB: 新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
RT @NydtyV3ODjb3cEB: 新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
RT @NydtyV3ODjb3cEB: 新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
RT @NydtyV3ODjb3cEB: 新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
新型コロナでME/CFS発症は393%増加、と。 うちもだしな。 https://t.co/9wE7LhwWAQ
RT @BrainInflCollab: According to a new longitudinal study from the NIH RECOVER initiative, a SARS-CoV-2 infection increases your risk of d…
RT @BrainInflCollab: According to a new longitudinal study from the NIH RECOVER initiative, a SARS-CoV-2 infection increases your risk of d…
RT @BrainInflCollab: According to a new longitudinal study from the NIH RECOVER initiative, a SARS-CoV-2 infection increases your risk of d…
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study | Journal of General Internal Medicine SARS-CoV-2 infection increases your risk of developing ME/CFS by 393% https://t.co/1JStuz9y2s
RT @BrainInflCollab: According to a new longitudinal study from the NIH RECOVER initiative, a SARS-CoV-2 infection increases your risk of d…
RT @BrainInflCollab: According to a new longitudinal study from the NIH RECOVER initiative, a SARS-CoV-2 infection increases your risk of d…
RT @BrainInflCollab: According to a new longitudinal study from the NIH RECOVER initiative, a SARS-CoV-2 infection increases your risk of d…
RT @BrainInflCollab: According to a new longitudinal study from the NIH RECOVER initiative, a SARS-CoV-2 infection increases your risk of d…
RT @BrainInflCollab: According to a new longitudinal study from the NIH RECOVER initiative, a SARS-CoV-2 infection increases your risk of d…
RT @jorgenponder: Enligt denna studie i USA femdubblar Covid risken för ME/CFS. Självrapporterade symtom vid besök och med en osmittad jämf…
RT @BrainInflCollab: According to a new longitudinal study from the NIH RECOVER initiative, a SARS-CoV-2 infection increases your risk of d…
RT @BrainInflCollab: According to a new longitudinal study from the NIH RECOVER initiative, a SARS-CoV-2 infection increases your risk of d…
According to a new longitudinal study from the NIH RECOVER initiative, a SARS-CoV-2 infection increases your risk of developing ME/CFS by 393%. Here are the study cliff notes... Full study: https://t.co/SWxkaEL8Rf
RECOVER-Adult研究の参加者 15,181人を対象に、筋痛性脳脊髄炎/慢性疲労症候群 (ME/CFS) の発生率を調査した。 SARS-CoV-2感染者のME/CFS発生リスクは、非感染者の約 4.93倍であった。感染者の 4.5%がME/CFSと診断され、そのうち 88.7%がlong COVIDの診断基準も満たしていた。 https://t.co/SjATWPydMe
Enligt denna studie i USA femdubblar Covid risken för ME/CFS. Självrapporterade symtom vid besök och med en osmittad jämförelsegrupp. 15k deltagare, de med svår akut covid ej alls medtagna i studien. https://t.co/WYPkgxc8ya https://t.co/bLA6wPbc3q
RT @falsel_net: #SARSCooV2 Infection Associated With Nearly Eightfold Increase in Chronic Fatigue Syndrome: https://t.co/EgajgSdlbi
RT @falsel_net: #SARSCooV2 Infection Associated With Nearly Eightfold Increase in Chronic Fatigue Syndrome: https://t.co/EgajgSdlbi
RT @falsel_net: #SARSCooV2 Infection Associated With Nearly Eightfold Increase in Chronic Fatigue Syndrome: https://t.co/EgajgSdlbi
#SARSCooV2 Infection Associated With Nearly Eightfold Increase in Chronic Fatigue Syndrome: https://t.co/EgajgSdlbi
・Covid-19は慢性疲労症候群のリスクを高める可能性が有る ・Covid-19患者は症候群を発症する可能性がほぼ5倍高い ・他の感染症もCFSのリスクを高める事が示されている https://t.co/mNtmc4oSlK
@WillRye You are incorrect. Just now I read the intro to the source study that is here - still it is percent of people who had acute covid, not of people who had long covid. https://t.co/7yvrYJ57Ny https://t.co/PTdnWwmdFV
RT @Redkiraz: Proportion de participants à RECOVER-Adultes qui répondaient aux critères de l'EM/SFC après Covid était de 4,5% contre 0,6% c…
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: incidence rate of ME/CFS followed from time of SARS-CoV-2 infection was 2.66 per 100 person-years while rate in matched uninfected was 0.93 per 100 person-years: https://t.co/A4qKyJoUzJ
RT @Angama_Market: COVID-19後の成人でME/CFS（筋痛性脳脊髄炎/慢性疲労症候群）発症率が約5倍に増加。感染から6か月以上後の追跡調査で、11,785人中4.5%がME/CFS診断基準を満たす一方、非感染者では0.6%。疲労や倦怠感の症状が日常生活に…
RT @Redkiraz: Proportion de participants à RECOVER-Adultes qui répondaient aux critères de l'EM/SFC après Covid était de 4,5% contre 0,6% c…
Yet another confirmation https://t.co/8YTbknc5Ct
Yet another confirmation... https://t.co/6GiZCeGmbd
@michaelmina_lab @indy_yet @GidMK 4.5% of those with SARS 2 infection meet full criteria for MECFS 6+ months later vs 0.2-1% pre pandemic rate of MECFS. That’s 4.5-22x’s the rate of MECFS we had before because of SARS 2. This is also an undercount because they excluded the hospitalized. https://t.co/L81fJjyHgr
Proportion de participants à RECOVER-Adultes qui répondaient aux critères de l'EM/SFC après Covid était de 4,5% contre 0,6% chez les participants non infectés Taux de Long Covid chez les participants atteints d'EM/SFC après COVID : 88,7% https://t.co/vRtgiGeBB6
3/3 Artikel ist neu, Studie vom 13.1.2025 "Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study" (Limitations: The ME/CFS clinical diagnostic criteria uses self-reported symptoms. ...) #COVID link.springer.com/article/10.1...
3/3 Artikel neu, Studie 13.1.2025 "Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study" (Limitations: The ME/CFS clinical diagnostic criteria uses self-reported symptoms. ...) https://t.co/rQfbBD9HnU
@surf4children @DavidJoffe64 It is Tat that leads to calcium overload in the hippocampus. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress https://t.co/m6Wfg6KMb3
@Adede2023 @FundamentalLack Source study—5x from COVID: "The incidence rate of ME/CFS in participants followed from time of SARS-CoV-2 infection was 2.66...per 100 person-years while the rate in matched uninfected participants was 0.93...per 100 person-years: a hazard ratio of 4.93" https://t.co/CTNOP8o6RS
RT @Angama_Market: COVID-19後の成人でME/CFS発症率が約5倍増加、感染予防が鍵。（一行版） https://t.co/LkG5EXEn3D
RT @Dan_Wyke: "ME/CFS is a diagnosable sequela that develops at an increased rate following SARS-CoV-2 infection." #MyalgicEncephalomyeliti…
RT @Dan_Wyke: "ME/CFS is a diagnosable sequela that develops at an increased rate following SARS-CoV-2 infection." #MyalgicEncephalomyeliti…
RT @Dan_Wyke: "ME/CFS is a diagnosable sequela that develops at an increased rate following SARS-CoV-2 infection." #MyalgicEncephalomyeliti…
RT @noren_elisabeth: Covid verkar utlösa ME hos 4,5% av de infekterade. Lägg dessutom till andra typer av covidutlöst sjukdom, och effekten…
➡️ Die "RECOVER-Adult-Studie" im Fachmagazin "Journal of General Internal Medicine" https://t.co/HvbJdHm56W
RT @carpe_diem0820: Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Stud…
RT @guty2370:
RT @guty2370:
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study | The Transmission | University of Nebraska Medical Center https://t.co/wzutHDFDof
RT @s4me_info: Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study — V…
RT @s4me_info: Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study — V…
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study — Vernon et al. https://t.co/TXhM2jgpf7 2/14
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study — Vernon et al. www.s4me.info/threads/inci... 2/14
RT @UUHSResearch: New study @JournalGIM “Incidence and Prevalence of Post‑COVID‑19 Myalgic Encephalomyelitis: A Report from the Observation…
RT @UUHSResearch: New study @JournalGIM “Incidence and Prevalence of Post‑COVID‑19 Myalgic Encephalomyelitis: A Report from the Observation…
New study @JournalGIM “Incidence and Prevalence of Post‑COVID‑19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER‑Adult Study,” reveals that infection with SARS-CoV-2, significantly increases the rate of (ME/CFS) among COVID-19 survivors. https://t.co/WpfdEzYSlh
DOI: 10.1007/s11606-024-09290-9 COVID後のME/CFSがある患者の88.7%はLong COVIDも患っていた >「ME/CFSはSARS-CoV-2感染の診断可能な後遺症である」と研究著者らは結論付けています。
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study | Journal of General Internal Medicine
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study https://t.co/FaKEXcgILT
RT @CenterRes: Vernon, S. D. et al. (2025) Incidence and prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A report from the Observat…
RT @nbykudn_udon: アメリカの研究で、コロナ感染後のME/CFSの発症率はパンデミック前の約15倍であったと。一昨日出たばかりの新しい論文ですね
New ME/CFS Research (Published 2025) Findings! This highlights the urgent need for greater awareness, funding, and support for those with Long COVID and ME/CFS. Full study: link.springer.com/article/10.1007/s11606-024-09290-9 #MECFS #LongCOVID
This studied how many people went on to develop ME after COVID. 4.5% developed full-blown ME, incl. moderate to complete interference with ability to walk, climb stairs, carry groceries, or move a chair. 39.5% developed an ME-like illness. A thread on these alarming findings
Vernon, S. D. et al. (2025) Incidence and prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A report from the Observational RECOVER-Adult Study. Journal of General Internal Medicine. Published online Jan 13, 2025. DOI: 10.1007/s11606-024-09290-9
RT @nbykudn_udon: アメリカの研究で、コロナ感染後のME/CFSの発症率はパンデミック前の約15倍であったと。一昨日出たばかりの新しい論文ですね
RT @nbykudn_udon: アメリカの研究で、コロナ感染後のME/CFSの発症率はパンデミック前の約15倍であったと。一昨日出たばかりの新しい論文ですね
RT @nbykudn_udon: アメリカの研究で、コロナ感染後のME/CFSの発症率はパンデミック前の約15倍であったと。一昨日出たばかりの新しい論文ですね
RT @nbykudn_udon: アメリカの研究で、コロナ感染後のME/CFSの発症率はパンデミック前の約15倍であったと。一昨日出たばかりの新しい論文ですね
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study （新型コロナ感染症後の筋痛性脳脊髄炎の発生率と有病率： 観察研究RECOVER-Adult Studyからの報告） https://t.co/oAxjHfm09A
アメリカの研究で、コロナ感染後のME/CFSの発症率はパンデミック前の約15倍であったと。一昨日出たばかりの新しい論文ですね
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
Research reference: Vernon, Suzanne D. et al Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study. J GEN INTERN MED (2025). doi.org/10.1007/s116... rdcu.be/d6cU0
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study link.springer.com/article/10.1...
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
"Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study." Vernon, S.D., Zheng, T., Do, H. et al. J GEN INTERN MED (2025). https://t.co/RSqJCu9yJq #MECFS #MEresearch
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
RT @mecfsskeptic: 9) Link to the study: https://t.co/T8RXmyXybv Link to discussion on the Science for ME forum: https://t.co/Ud8lPFEBLq
STUDY: Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study https://t.co/DfEvFvwN5e Published: 13 January 2025 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may occur after infection. How often
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
DOI: 10.1007/s11606-024-09290-9 米NIHによるRECOVERプログラムにより、SARS-CoV-2は筋痛性脳脊髄炎/慢性疲労症候群(ME/CFS)の増加に関連するとの報告 新型コロナ感染後(後遺症, Long COVID)に発症することが多いME/CFSは、6ヶ月以上続く疲労感、運動後倦怠感、睡眠や認知障害などを特徴とする 研究チームはパンデミック前と比べた新規発症率が15倍高いことを発見した 感染によってME/CFS発症が増加するメカニズムを理解することで治療法発見に役立つだろう www.eurekalert.org/news-release...
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study | Journal of General Internal Medicine https://t.co/gAvKCXXRpf
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
ME/CFS leaders knew from the beginning of the pandemic there will be an increase of #MECFS cases after a COVID infection. « Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study » link.springer.com/article/10.1...
ME/CFS leaders knew from the beginning of the pandemic there will be an increase of #MECFS cases after a COVID infection. « Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study » https://t.co/PRJY2G7mzb
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study. https://t.co/lYvKYxwhj0
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study #MEartikler https://t.co/k7Ek5B6Weg
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
9) Link to the study: https://t.co/T8RXmyXybv Link to discussion on the Science for ME forum: https://t.co/Ud8lPFEBLq
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study https://t.co/sqwVfFepKV
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
Here's a link to the study she is discussing, published in the Journal of General Internal Medicine: "Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study" https://link.springer.com/article/10.1007/s11606-024-09290-9 @mecfs […]
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
RT @bhanlon15: 1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observatio…
1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study' 'RECOVER provides an unprecedented opportunity to study post-COVID-19 ME/CFS.' link.springer.com/article/10.1...
1/13/25, Springer Nature: 'Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study' 'RECOVER provides an unprecedented opportunity to study post-COVID-19 ME/CFS.' https://t.co/BMYxhJaiEI